Autopsy report · NCT03484234
Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-VII: Sirolimus-eluting (Ultimaster) vs. Everolimus-Eluting Stents (Xience)
Cause of deathOther
“At sponsor's discretion : The purpose of study is no longer maintained”
Life of this trial
- Registered 4 months before it started.
- Ran for about 1 year 1 month before it stopped.
- 36 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Seung-Jung Park
- Sponsor type
- University, hospital or other
- Conditions
- Coronary Artery Disease; Coronary Stenosis
- Interventions
- Ultimaster stent; Xience alpine stent
- Participants
- 36
- Sites
- 2
- Countries
- South Korea
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.